These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16879001)

  • 1. Somatropin therapy for children with prader-willi syndrome : guidelines for use.
    Lindgren AC
    Treat Endocrinol; 2006; 5(4):223-8. PubMed ID: 16879001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatropin therapy in adults with Prader-Willi syndrome.
    Höybye C; Thorén M
    Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.
    Burman P; Ritzén EM; Lindgren AC
    Endocr Rev; 2001 Dec; 22(6):787-99. PubMed ID: 11739333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
    Jin YY; Luo FH
    Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
    J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extreme obesity in Prader-Willi Syndrome (PWS)].
    Damiano J; Ficko C; Garrabé E; Mayaudon H; Dupuy O; Carmoi T; Bordier L; Bauduceau B
    Rev Med Interne; 2003 Sep; 24(9):617-20. PubMed ID: 12951183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 14-year-old male patient with diagnosis of Prader-Willi syndrome in Ethiopia: a case report.
    Belay KE; Ayalew BL; Amogne MT; Alemneh TA; Geletew TK
    J Med Case Rep; 2023 Dec; 17(1):530. PubMed ID: 38143282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome.
    Eiholzer U; Bachmann S; l'Allemand D
    Horm Res; 2000; 53 Suppl 3():44-52. PubMed ID: 10971104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy.
    Eiholzer U; l'Allemand D; van der Sluis I; Steinert H; Gasser T; Ellis K
    Horm Res; 2000; 53(4):200-6. PubMed ID: 11044804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
    Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth hormone usage in Prader-Willi syndrome].
    Damiani D
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):833-8. PubMed ID: 18797590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition in Prader-Willi syndrome: assessment and effects of growth hormone administration.
    Davies PS
    Acta Paediatr Suppl; 1999 Dec; 88(433):105-8. PubMed ID: 10626557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study.
    Kido Y; Sakazume S; Abe Y; Oto Y; Itabashi H; Shiraishi M; Yoshino A; Tanaka Y; Obata K; Murakami N; Nagai T
    Am J Med Genet A; 2013 Sep; 161A(9):2167-73. PubMed ID: 23897656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.